2nd Annual NASH Summit 2018

Kongressthemen
As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical development.

Across 3 parallel streams of learning, 48 expert speakers including Gilead, Allergan and Novartis will share advances in:

. Validating non-invasive biomarkers to confidently stratify patients and enhance clinical response

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Speakers: Jason Campagna (Intercept Pharmaceuticals), Philip Just Larsen (Sanofi), Jamie Bates (Gilead Sciences), Dean Hurn (Genfit), Edgar Charles (Bristol-Myers Squibb)

URLs: Brochure: https://go.evvnt.com/169819-1 Booking: https://go.evvnt.com/169819-2

Frau Aarti Diwan